Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Latency, Integration, and Reactivation of Human Herpesvirus-6.

Pantry SN, Medveczky PG.

Viruses. 2017 Jul 24;9(7). pii: E194. doi: 10.3390/v9070194. Review.

2.

Is inherited human herpesvirus 6 the perpetrator behind some cases of chronic fatigue syndrome?

Lum E, Medveczky MM, Medveczky PG.

Future Microbiol. 2014;9(4):433-6. doi: 10.2217/fmb.14.11. No abstract available.

PMID:
24810341
3.

Persistent human herpesvirus-6 infection in patients with an inherited form of the virus.

Pantry SN, Medveczky MM, Arbuckle JH, Luka J, Montoya JG, Hu J, Renne R, Peterson D, Pritchett JC, Ablashi DV, Medveczky PG.

J Med Virol. 2013 Nov;85(11):1940-6. doi: 10.1002/jmv.23685. Epub 2013 Jul 25.

4.

Mapping the telomere integrated genome of human herpesvirus 6A and 6B.

Arbuckle JH, Pantry SN, Medveczky MM, Prichett J, Loomis KS, Ablashi D, Medveczky PG.

Virology. 2013 Jul 20;442(1):3-11. doi: 10.1016/j.virol.2013.03.030. Epub 2013 May 4.

5.

Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunction.

Montoya JG, Neely MN, Gupta S, Lunn MR, Loomis KS, Pritchett JC, Polsky B, Medveczky PG.

J Clin Virol. 2012 Sep;55(1):40-5. doi: 10.1016/j.jcv.2012.05.016. Epub 2012 Jul 5.

PMID:
22770640
6.

Chromosomally integrated human herpesvirus 6: questions and answers.

Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, Flamand L, Gautheret-Dejean A, Hall CB, Kamble RT, Kuehl U, Lassner D, Lautenschlager I, Loomis KS, Luppi M, Lusso P, Medveczky PG, Montoya JG, Mori Y, Ogata M, Pritchett JC, Rogez S, Seto E, Ward KN, Yoshikawa T, Razonable RR.

Rev Med Virol. 2012 May;22(3):144-55. doi: 10.1002/rmv.715. Epub 2011 Nov 4. Review.

7.

The molecular biology of human herpesvirus-6 latency and telomere integration.

Arbuckle JH, Medveczky PG.

Microbes Infect. 2011 Aug;13(8-9):731-41. doi: 10.1016/j.micinf.2011.03.006. Epub 2011 Mar 31. Review.

8.

Review, part 1: Human herpesvirus-6-basic biology, diagnostic testing, and antiviral efficacy.

Flamand L, Komaroff AL, Arbuckle JH, Medveczky PG, Ablashi DV.

J Med Virol. 2010 Sep;82(9):1560-8. doi: 10.1002/jmv.21839. Review. No abstract available.

PMID:
20648610
9.

The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro.

Arbuckle JH, Medveczky MM, Luka J, Hadley SH, Luegmayr A, Ablashi D, Lund TC, Tolar J, De Meirleir K, Montoya JG, Komaroff AL, Ambros PF, Medveczky PG.

Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5563-8. doi: 10.1073/pnas.0913586107. Epub 2010 Mar 8.

11.

Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication.

Pantry SN, Medveczky PG.

Semin Cancer Biol. 2009 Jun;19(3):153-7. doi: 10.1016/j.semcancer.2009.02.010. Epub 2009 Feb 21. Review.

12.

Identification of mitochondrial genome concatemers in AIDS-associated lymphomas and lymphoid cell lines.

Bedoya F, Medveczky MM, Lund TC, Perl A, Horvath J, Jett SD, Medveczky PG.

Leuk Res. 2009 Nov;33(11):1499-504. doi: 10.1016/j.leukres.2009.03.012. Epub 2009 Apr 11.

13.

Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro.

Medveczky MM, Sherwood TA, Klein TW, Friedman H, Medveczky PG.

BMC Med. 2004 Sep 15;2:34.

16.

The terminal repeats and latency-associated nuclear antigen of herpesvirus saimiri are essential for episomal persistence of the viral genome.

Collins CM, Medveczky MM, Lund T, Medveczky PG.

J Gen Virol. 2002 Sep;83(Pt 9):2269-2278. doi: 10.1099/0022-1317-83-9-2269.

PMID:
12185282
17.

The herpesvirus saimiri tip484 and tip488 proteins both stimulate lck tyrosine protein kinase activity in vivo and in vitro.

Kjellen P, Amdjadi K, Lund TC, Medveczky PG, Sefton BM.

Virology. 2002 Jun 5;297(2):281-8.

18.

Genetic requirements for the episomal maintenance of oncogenic herpesvirus genomes.

Collins CM, Medveczky PG.

Adv Cancer Res. 2002;84:155-74. Review.

PMID:
11883526
19.

Activation of the Lck tyrosine protein kinase by the Herpesvirus saimiri tip protein involves two binding interactions.

Hartley DA, Amdjadi K, Hurley TR, Lund TC, Medveczky PG, Sefton BM.

Virology. 2000 Oct 25;276(2):339-48.

20.

The Src-family kinase Lck can induce STAT3 phosphorylation and DNA binding activity.

Lund TC, Coleman C, Horvath E, Sefton BM, Jove R, Medveczky MM, Medveczky PG.

Cell Signal. 1999 Nov;11(11):789-96.

PMID:
10617281
21.

Activation of the lck tyrosine-protein kinase by the binding of the tip protein of herpesvirus saimiri in the absence of regulatory tyrosine phosphorylation.

Hartley DA, Hurley TR, Hardwick JS, Lund TC, Medveczky PG, Sefton BM.

J Biol Chem. 1999 Jul 16;274(29):20056-9.

22.
23.

The Lck binding domain of herpesvirus saimiri tip-484 constitutively activates Lck and STAT3 in T cells.

Lund TC, Prator PC, Medveczky MM, Medveczky PG.

J Virol. 1999 Feb;73(2):1689-94.

24.

In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.

Medveczky MM, Horvath E, Lund T, Medveczky PG.

AIDS. 1997 Sep;11(11):1327-32.

PMID:
9302441
25.

Activation of STAT transcription factors by herpesvirus Saimiri Tip-484 requires p56lck.

Lund TC, Garcia R, Medveczky MM, Jove R, Medveczky PG.

J Virol. 1997 Sep;71(9):6677-82.

26.
28.
29.
30.
31.

Expression of IL-2 and IL-4 in T lymphocytes transformed by herpesvirus saimiri.

Chou CS, Medveczky MM, Geck P, Vercelli D, Medveczky PG.

Virology. 1995 Apr 20;208(2):418-26.

32.

A polycistronic transcript in transformed cells encodes the dihydrofolate reductase of herpesvirus saimiri.

Whitaker S, Geck P, Medveczky MM, Cus J, Kung SH, Lund T, Medveczky PG.

Virus Genes. 1995;10(2):163-72.

PMID:
8560776
33.

Induction of a herpesvirus saimiri small RNA AU binding factor (AUBF70) activity and lymphokine mRNAs by T cell mitogens.

Chou CS, Geck P, Medveczky MM, Hernandez OM, Medveczky PG.

Arch Virol. 1995;140(3):415-35.

PMID:
7733817
34.

Herpesvirus saimiri small RNA and interleukin-4 mRNA AUUUA repeats compete for sequence-specific factors including a novel 70K protein.

Geck P, Medveczky MM, Chou CS, Brown A, Cus J, Medveczky PG.

J Gen Virol. 1994 Sep;75 ( Pt 9):2293-301. Erratum in: J Gen Virol 1994 Dec;75(Pt 12):3688.

PMID:
8077927
35.

Small RNA expression from the oncogenic region of a highly oncogenic strain of herpesvirus saimiri.

Geck P, Whitaker SA, Medveczky MM, Last TJ, Medveczky PG.

Virus Genes. 1994 Jan;8(1):25-34.

PMID:
8209420
36.

Expression of the collagen-like putative oncoprotein of Herpesvirus saimiri in transformed T cells.

Medveczky MM, Geck P, Vassallo R, Medveczky PG.

Virus Genes. 1993 Dec;7(4):349-65.

PMID:
8122395
37.

IL-2 independent growth and cytotoxicity of herpesvirus saimiri-infected human CD8 cells and involvement of two open reading frame sequences of the virus.

Medveczky MM, Geck P, Sullivan JL, Serbousek D, Djeu JY, Medveczky PG.

Virology. 1993 Oct;196(2):402-12.

PMID:
8396794
38.

Western blotting and polymerase chain reaction for diagnosis of HIV infection.

Medveczky PG.

J Fla Med Assoc. 1992 Jan;79(1):47-50. No abstract available.

PMID:
1548458
39.

Expression of collagenlike sequences by a tumor virus, herpesvirus saimiri.

Geck P, Whitaker SA, Medveczky MM, Medveczky PG.

J Virol. 1991 Dec;65(12):7084. No abstract available.

40.

Inhibition of Epstein-Barr virus production in P3HR-1 cells by Epstein-Barr virus-seropositive human serum.

Sairenji T, Bertoni G, Medveczky MM, Medveczky PG, Humphreys RE.

Intervirology. 1991;32(1):37-51.

PMID:
1849877
41.

Expression of collagenlike sequences by a tumor virus, herpesvirus saimiri.

Geck P, Whitaker SA, Medveczky MM, Medveczky PG.

J Virol. 1990 Jul;64(7):3509-15. Erratum in: J Virol. 1991 Dec;65(12):7084.

42.

Herpesvirus saimiri strains from three DNA subgroups have different oncogenic potentials in New Zealand white rabbits.

Medveczky MM, Szomolanyi E, Hesselton R, DeGrand D, Geck P, Medveczky PG.

J Virol. 1989 Sep;63(9):3601-11.

43.

Arrangement of repetitive sequences in the genome of herpesvirus Sylvilagus.

Medveczky MM, Geck P, Clarke C, Byrnes J, Sullivan JL, Medveczky PG.

J Virol. 1989 Feb;63(2):1010-4.

44.
45.

Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.

Sairenji T, Bertoni G, Medveczky MM, Medveczky PG, Nguyen QV, Humphreys RE.

J Virol. 1988 Aug;62(8):2614-21.

Supplemental Content

Loading ...
Support Center